Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease

Statin-based treatments reduce cardiovascular disease (CVD) risk in patients with non-dialysis chronic kidney disease (CKD), but it is unclear which regimen is the most cost-effective. We used the Study of Heart and Renal Protection (SHARP) CKD-CVD policy model to evaluate the effect of statins and...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlackow, Iryna, Kent, Seamus, Herrington, William, Emberson, Jonathan, Haynes, Richard, Reith, Christina, Collins, Rory, Landray, Martin J., Gray, Alastair, Baigent, Colin, Mihaylova, Borislava
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595178/
https://www.ncbi.nlm.nih.gov/pubmed/31005271
http://dx.doi.org/10.1016/j.kint.2019.01.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595178/
https://www.ncbi.nlm.nih.gov/pubmed/31005271
http://dx.doi.org/10.1016/j.kint.2019.01.028

Ejemplares similares